Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis.
Kun-Han LeeYing-Fan ChenWan-Yu YehJiunn-Tyng YehTzu-Han YangChian-Ying ChouYuh-Lih ChangWei-Ting WangChern-En ChiangChen-Huan ChenBabangida S ChoriPublished in: Age and ageing (2022)
In patients aged 80 years or older with AF, NOACs have better outcomes than VKAs regarding efficacy and safety profiles. Edoxaban and apixaban may be preferred treatment options since they are safer than other antithrombotic strategies.
Keyphrases
- atrial fibrillation
- end stage renal disease
- systematic review
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- physical activity
- venous thromboembolism
- left atrial
- adipose tissue
- left atrial appendage
- catheter ablation
- patient reported outcomes
- skeletal muscle
- insulin resistance
- blood brain barrier
- percutaneous coronary intervention
- meta analyses